Asthma electrocardiogram: Difference between revisions
Usama Talib (talk | contribs) |
m Bot: Removing from Primary care |
||
| Line 12: | Line 12: | ||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
{{WH}} | |||
{{WS}} | |||
[[Category:Pulmonology]] | [[Category:Pulmonology]] | ||
[[Category:Immunology]] | [[Category:Immunology]] | ||
[[Category:Emergency medicine]] | [[Category:Emergency medicine]] | ||
[[Category:Mature chapter]] | [[Category:Mature chapter]] | ||
Latest revision as of 20:30, 29 July 2020
|
Asthma Microchapters |
|
Diagnosis |
|---|
|
Other Diagnostic Studies |
|
Treatment |
|
Case Studies |
|
Asthma electrocardiogram On the Web |
|
American Roentgen Ray Society Images of Asthma electrocardiogram |
|
Risk calculators and risk factors for Asthma electrocardiogram |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Lakshmi Gopalakrishnan, M.B.B.S. [2]
Overview
ECG in asthmatics with acute severe exacerbation may reveal sinus tachycardia and a right heart strain pattern. However, the administration of a β2-agonist may relieve symptoms and hence result in a paradoxical decrease in heart rate. The presence of supraventricular tachycardia should raise a suspicion of theophylline toxicity.[1]
Electrocardiogram
ECG in asthmatics with acute severe exacerbation may reveal sinus tachycardia and a right heart strain pattern. However, the administration of a β2-agonist may relieve symptoms and hence result in a paradoxical decrease in heart rate. The presence of supraventricular tachycardia should raise a suspicion of theophylline toxicity.[1]
- Abnormalities in S1Q3T3 may be seen in bronchospasm.